Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 31,700 shares at $232.04 ($7.2M) on 2020-01-31, disclosed to the SEC on 2020-02-04.
Open-market sale of $7.2M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $224.02 | 1,700 | $381K | 5.3% |
| 2 | $224.98 | 1,858 | $418K | 5.8% |
| 3 | $224.98 | 1,858 | $418K | 5.8% |
| 4 | $226.32 | 4,198 | $950K | 13.2% |
| 5 | $226.32 | 4,198 | $950K | 13.2% |
| 6 | $227.01 | 5,644 |
| $1.3M |
| 17.8% |
| 7 | $227.01 | 5,644 | $1.3M | 17.8% |
| 8 | $227.66 | 300 | $68K | 0.9% |
| 9 | $228.33 | 600 | $137K | 1.9% |
| 10 | $229.90 | 500 | $115K | 1.6% |
| 11 | $230.87 | 1,200 | $277K | 3.8% |
| 12 | $232.04 | 1,200 | $278K | 3.9% |
| 13 | $233.13 | 1,800 | $420K | 5.8% |
| 14 | $234.15 | 900 | $211K | 2.9% |
| 15 | $235.40 | 100 | $24K | 0.3% |
| Total | $227.42 avg | 31,700 | $7.2M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |